cefixime has been researched along with Pneumococcal Infections in 13 studies
Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.
Pneumococcal Infections: Infections with bacteria of the species STREPTOCOCCUS PNEUMONIAE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The bacteriological eradication rates of Streptococcus pneumoniae from sputum of patients experiencing acute exacerbations of chronic bronchitis (WHO definition) have been compared following therapy with either cefuroxime axetil 250 mg b." | 9.09 | Bacteriological eradication of Streptococcus pneumoniae from patients with acute exacerbations of chronic bronchitis: cefuroxime axetil versus cefixime. ( Geslin, P; Leblanc, F; Petitpretz, P; Rio, Y; Zuck, P, 1999) |
| "Patients with purulent exacerbation of chronic bronchitis were randomized to receive either a single 400-mg daily dose of cefixime or 250 mg of cephalexin, orally, four times a day." | 9.06 | Randomized comparative study of cefixime versus cephalexin in acute bacterial exacerbations of chronic bronchitis. ( Kalbfleisch, JH; Roberson, D; Sarubbi, F; Verghese, A, 1990) |
| "Previous studies using the chinchilla animal model demonstrated that the third generation cephalosporin cefixime (Suprax) with split dosing was as effective as ampicillin in sterilizing the middle ear cleft when infected with S." | 5.29 | An experimental study of cefixime in the treatment of Streptococcus pneumoniae otitis media. ( Dolitsky, JN; Doyle, WJ; Magit, AE; Rosenfeld, RM; Seroky, JT; Swarts, JD, 1994) |
| "The bacteriological eradication rates of Streptococcus pneumoniae from sputum of patients experiencing acute exacerbations of chronic bronchitis (WHO definition) have been compared following therapy with either cefuroxime axetil 250 mg b." | 5.09 | Bacteriological eradication of Streptococcus pneumoniae from patients with acute exacerbations of chronic bronchitis: cefuroxime axetil versus cefixime. ( Geslin, P; Leblanc, F; Petitpretz, P; Rio, Y; Zuck, P, 1999) |
| "Patients with purulent exacerbation of chronic bronchitis were randomized to receive either a single 400-mg daily dose of cefixime or 250 mg of cephalexin, orally, four times a day." | 5.06 | Randomized comparative study of cefixime versus cephalexin in acute bacterial exacerbations of chronic bronchitis. ( Kalbfleisch, JH; Roberson, D; Sarubbi, F; Verghese, A, 1990) |
| " Single doses of each agent were administered and serum concentrations were collected over the standard dosing period of 24 h for all study regimens." | 2.70 | Pharmacodynamics of ceftriaxone and cefixime against community-acquired respiratory tract pathogens. ( Ambrose, PG; Nicolau, DP; Nightingale, CH; Owens, RC; Quintiliani, R; Tessier, P, 2001) |
| "Amoxicillin was by far the most effective antibiotic when considering its intrinsic activity (96% of the PRSP inhibited at 2 mg/l), the inhibitory quotient (100% of the PRSP > 1 vs 69." | 1.30 | Choice of an oral beta-lactam antibiotic for infections due to penicillin-resistant Streptococcus pneumoniae. ( Goldstein, FW, 1997) |
| "Previous studies using the chinchilla animal model demonstrated that the third generation cephalosporin cefixime (Suprax) with split dosing was as effective as ampicillin in sterilizing the middle ear cleft when infected with S." | 1.29 | An experimental study of cefixime in the treatment of Streptococcus pneumoniae otitis media. ( Dolitsky, JN; Doyle, WJ; Magit, AE; Rosenfeld, RM; Seroky, JT; Swarts, JD, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 11 (84.62) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carannante, N | 1 |
| Pallotto, C | 1 |
| Bernardo, M | 1 |
| Mallardo, E | 1 |
| Di Caprio, G | 1 |
| Palmiero, G | 1 |
| Attanasio, V | 1 |
| Tascini, C | 1 |
| Barry, AL | 1 |
| Fuchs, PC | 1 |
| Magit, AE | 1 |
| Dolitsky, JN | 1 |
| Doyle, WJ | 2 |
| Swarts, JD | 2 |
| Seroky, JT | 1 |
| Rosenfeld, RM | 2 |
| Friedland, IR | 1 |
| Goldstein, FW | 1 |
| Verhaegen, J | 1 |
| Verbist, L | 1 |
| Matsumoto, Y | 1 |
| Ludwig, E | 1 |
| Zuck, P | 1 |
| Petitpretz, P | 1 |
| Geslin, P | 1 |
| Rio, Y | 1 |
| Leblanc, F | 1 |
| Owens, RC | 1 |
| Tessier, P | 1 |
| Nightingale, CH | 1 |
| Ambrose, PG | 1 |
| Quintiliani, R | 1 |
| Nicolau, DP | 1 |
| Seroky, J | 1 |
| Pinero, BP | 1 |
| Ottolini, MG | 1 |
| Ascher, DP | 1 |
| Cieslak, TJ | 1 |
| Modica-Lucero, S | 1 |
| Verghese, A | 1 |
| Roberson, D | 1 |
| Kalbfleisch, JH | 1 |
| Sarubbi, F | 1 |
1 review available for cefixime and Pneumococcal Infections
| Article | Year |
|---|---|
Cefixime therapy for otitis media.
Topics: Acute Disease; Amoxicillin; Anti-Infective Agents; Cefixime; Cefotaxime; Humans; Otitis Media with E | 1993 |
4 trials available for cefixime and Pneumococcal Infections
| Article | Year |
|---|---|
Cefixime in the treatment of respiratory and urinary tract infections.
Topics: Adult; Cefixime; Cefotaxime; Cephalosporins; Child; Humans; Otitis Media; Pneumococcal Infections; R | 1998 |
Bacteriological eradication of Streptococcus pneumoniae from patients with acute exacerbations of chronic bronchitis: cefuroxime axetil versus cefixime.
Topics: Adult; Aged; Aged, 80 and over; Bronchitis; Cefixime; Cefuroxime; Cephalosporins; Chronic Disease; D | 1999 |
Pharmacodynamics of ceftriaxone and cefixime against community-acquired respiratory tract pathogens.
Topics: Administration, Oral; Adult; Blood Bactericidal Activity; Cefixime; Ceftriaxone; Cephalosporins; Com | 2001 |
Randomized comparative study of cefixime versus cephalexin in acute bacterial exacerbations of chronic bronchitis.
Topics: Acute Disease; Bronchitis; Cefixime; Cefotaxime; Cephalexin; Chronic Disease; Gram-Negative Bacteria | 1990 |
8 other studies available for cefixime and Pneumococcal Infections
| Article | Year |
|---|---|
Breakthrough pneumonia, meningitis and bloodstream infection due to
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacteremia; Cefixime; Female; Humans; Incidence; Italy; Ma | 2019 |
Methods for predicting susceptibility of Streptococcus pneumoniae to cefixime.
Topics: Cefixime; Cefotaxime; Drug Resistance, Microbial; Humans; In Vitro Techniques; Microbial Sensitivity | 1995 |
An experimental study of cefixime in the treatment of Streptococcus pneumoniae otitis media.
Topics: Acoustic Impedance Tests; Acute Disease; Ampicillin; Animals; Anti-Infective Agents; Cefixime; Cefot | 1994 |
Choice of an oral beta-lactam antibiotic for infections due to penicillin-resistant Streptococcus pneumoniae.
Topics: Administration, Oral; Amoxicillin; beta-Lactam Resistance; Cefaclor; Cefixime; Cefotaxime; Cefpodoxi | 1997 |
In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefaclor; Cefadroxil; Cef | 1998 |
Combination cefixime/amoxicillin against penicillin-resistant Streptococcus pneumoniae infection.
Topics: Amoxicillin; Animals; Cefixime; Cefotaxime; Cephalosporins; Drug Synergism; Drug Therapy, Combinatio | 1998 |
Third-generation cephalosporins in the treatment of acute pneumococcal otitis media. An animal study.
Topics: Acoustic Impedance Tests; Acute Disease; Ampicillin; Animals; Cefixime; Cefotaxime; Ceftibuten; Ceph | 1992 |
Pneumococcal bacteremia during oral treatment with cefixime for otitis media.
Topics: Administration, Oral; Cefixime; Cefotaxime; Drug Resistance, Microbial; Humans; Infant; Male; Otitis | 1991 |